Head and Neck Squamous Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2009-04-23
  Clinical Trial Update: The IRESSA Novel Head and Neck Chemotherapy Evaluation Study [Phase 2]

  Phase 2 study evaluating IRESSA (gefitinib) in head and neck squamous cell carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2008-06-04
  Clinical Trial Update: Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

  Phase 1/2 trial evaluating the combination of docetaxel, cisplatin, and 5-fluorouracil for locally advanced head and neck squamous cell carc…

• CLINICAL_TRIALS trial_result · 2008-06-03
  Clinical Trial Update: Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 2]

  Phase 2 trial update of combination chemotherapy for locally advanced Head and Neck Squamous Cell Carcinoma; the study status is completed.

• CLINICAL_TRIALS research · 2008-04-11
  Clinical Trial Update: Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]

  A Phase 2 clinical trial comparing 3D-conformal radiotherapy (3D-CRT) with intensity-modulated radiotherapy (IMRT) for head and neck squamou…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer [Phase 1]

  Phase 1 pilot study evaluating paclitaxel in combination with radiation therapy for locally advanced head and neck squamous cell carcinoma h…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-01-28
  FDA Approved: BLEOMYCIN — Original Application (Fresenius Kabi USA, LLC)

  The FDA approved Fresenius Kabi USA's original ANDA for bleomycin sulfate, making a generic version of bleomycin available. Bleomycin is an …

• CLINICAL_TRIALS trial_result · 2007-12-27
  Clinical Trial Update: Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

  The study evaluating temsirolimus in advanced head and neck squamous cell carcinoma has completed; Wyeth is now a subsidiary of Pfizer.

• CLINICAL_TRIALS trial_result · 2007-10-04
  Clinical Trial Update: TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN [Phase 3]

  A phase 3 trial comparing TAX + cisplatin + 5-FU versus cisplatin + 5-FU in head and neck squamous cell carcinoma has completed.